CN105770116A - Medicine composition for treating burn and scald, method for preparing medicine composition and application thereof - Google Patents
Medicine composition for treating burn and scald, method for preparing medicine composition and application thereof Download PDFInfo
- Publication number
- CN105770116A CN105770116A CN201610160769.9A CN201610160769A CN105770116A CN 105770116 A CN105770116 A CN 105770116A CN 201610160769 A CN201610160769 A CN 201610160769A CN 105770116 A CN105770116 A CN 105770116A
- Authority
- CN
- China
- Prior art keywords
- parts
- borneol
- beeswax
- raw material
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims abstract description 13
- 239000000203 mixture Substances 0.000 title abstract description 12
- 229940079593 drug Drugs 0.000 title description 14
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 66
- 235000013871 bee wax Nutrition 0.000 claims abstract description 55
- 239000012166 beeswax Substances 0.000 claims abstract description 55
- 239000002994 raw material Substances 0.000 claims abstract description 52
- 239000002674 ointment Substances 0.000 claims abstract description 19
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 13
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 13
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 11
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 64
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 64
- 229940116229 borneol Drugs 0.000 claims description 64
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 64
- 239000008194 pharmaceutical composition Substances 0.000 claims description 48
- 239000008159 sesame oil Substances 0.000 claims description 44
- 235000011803 sesame oil Nutrition 0.000 claims description 44
- 244000020518 Carthamus tinctorius Species 0.000 claims description 32
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 22
- 240000004980 Rheum officinale Species 0.000 claims description 14
- 241000050051 Chelone glabra Species 0.000 claims description 13
- 235000008081 Rheum officinale Nutrition 0.000 claims description 13
- 244000061520 Angelica archangelica Species 0.000 claims description 12
- 244000157790 Buglossoides arvense Species 0.000 claims description 12
- 235000004256 Buglossoides arvense Nutrition 0.000 claims description 12
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 12
- 244000153955 Reynoutria sachalinensis Species 0.000 claims description 11
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 11
- 241000218691 Cupressaceae Species 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 230000003760 hair shine Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 241000123069 Ocyurus chrysurus Species 0.000 claims 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims 1
- 238000002386 leaching Methods 0.000 claims 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims 1
- 235000021286 stilbenes Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 208000002193 Pain Diseases 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 20
- 230000008901 benefit Effects 0.000 abstract description 7
- 231100000614 poison Toxicity 0.000 abstract description 7
- 238000010926 purge Methods 0.000 abstract description 7
- 230000002924 anti-infective effect Effects 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 230000004089 microcirculation Effects 0.000 abstract description 4
- 239000003440 toxic substance Substances 0.000 abstract description 4
- 230000000740 bleeding effect Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 230000001976 improved effect Effects 0.000 abstract description 2
- 241000628997 Flos Species 0.000 abstract 1
- 206010048038 Wound infection Diseases 0.000 abstract 1
- 230000001338 necrotic effect Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 21
- 206010052428 Wound Diseases 0.000 description 19
- 241001149655 Rubia tinctorum Species 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000000202 analgesic effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000007797 corrosion Effects 0.000 description 3
- 238000005260 corrosion Methods 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000001114 myogenic effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- DTGKSKDOIYIVQL-QXFUBDJGSA-N (-)-borneol Chemical compound C1C[C@]2(C)[C@H](O)C[C@H]1C2(C)C DTGKSKDOIYIVQL-QXFUBDJGSA-N 0.000 description 1
- 229930006703 (-)-borneol Natural products 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 241001050829 Arnebia guttata Species 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 240000000572 Blumea balsamifera Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000907904 Dipterocarpus Species 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 208000013935 Electric injury Diseases 0.000 description 1
- 206010069808 Electrical burn Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 241000576429 Forsythia suspensa Species 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 241001079007 Phellodendron chinense Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 240000009235 Rubia cordifolia Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 241000951473 Schizonepeta Species 0.000 description 1
- 208000012642 Sexual Trauma Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 240000006688 Telosma cordata Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 239000009416 jing wan hong Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Insects & Arthropods (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine composition for treating burn and scald, a method for preparing the medicine composition and application thereof. The medicine composition mainly comprises, by weight, 10-30 parts of radix rubiae, 7-17 parts of cortex phellodendri, 20-40 parts of radix scutellariae, 50-80 parts of radix angelicae sinensis, 20-40 parts of radix angelicae dahuricae, 10-30 parts of rhizoma polygoni cuspidate, 7-17 parts of myrrh, 30-50 parts of radix arnebiae seu lithospermi, 20-40 parts of radix glycyrrhizae, 10-30 parts of borneolum syntheticum, 35-65 parts of radix et rhizoma rhei, 10-30 parts of radix astragali, 10-30 parts of flos carthami and 30-60 parts of beeswax. The medicine composition, the method and the application have the advantages that the medicine composition has functions of cooling blood to stop bleeding, relieving swelling and pain, purging fire, removing toxic substances, removing necrotic tissues and promoting tissue regeneration, the micro-circulation capacity and the healing ability of wounded tissues can be improved, the medicine composition is extremely high in anti-infection capacity, and miraculous effects can be clinically realized for slight, moderate and severe burn and scald and different types of wound infection; the method is easy to implement, and effective components in raw materials can be reserved to the greatest extent; patients can conveniently smear and use the ointment medicine composition, and the medicine composition can directly act on burn sites of the patients, can become effective fast and is convenient to use.
Description
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of treat the pharmaceutical composition of burn and scald, its preparation side
Method and application.
Background technology
Burn (include scald) be a kind of common by hot water, deep fat, gunpowder, chemicals etc. cause prominent
Sending out sexual trauma, its burn and scald degree is divided into slightly, moderate and severe.Be presently used for treating various burn,
The medicament scalded is the most, and methods for the treatment of is the most varied.
From traditional Chinese medical science angle, main employing external application occlusive dressing, i.e. apply the ointment on the surface of a wound.Burn in traditional Chinese medicinal ointment and scald
Vulnerary Sino-U.S. treasured moistens ointment and jingwanhong soft plaster result for the treatment of is best, is the first-selection of burned patient, also obtains
The favorable comment of burned patient, but MEBO is in clinical treatment uses, and also there is also some shortcomings
Part: one is that pain relieving is slower than effect, the liquefaction phase is longer, wound face healing time is longer;Two is that traditional Chinese medicinal ointment is main
For the surface of a wound of light moderate burn, it controls to infect the best and analgesic effect general, often needs auxiliary in treatment
Use antibiotic.From doctor trained in Western medicine angle, the most simple doctor trained in Western medicine operative treatment burn typically uses Dry Therapy,
I.e. trauma surface infestation is carried out block therapy, severe burn must be carried out operation and cut scab, skin-grafting, its institute
There is the problem that one be can not pain relieving in time, easily infect, particularly self-skin transplant operative treatment,
Increase the weight of the misery of patient, expand wound face;Two is that surgery cost is high, adds the mental burden of patient
And financial burden, cause some patient midways to abandon treatment;It is that treatment time is long again, and it is also possible to leaves
Scar, even resulting in disfeatures disables, dysfunction.
Summary of the invention
In order to solve the problems referred to above that prior art exists, the invention provides a kind of medicine treating burn and scald
Composition, its preparation method and application.Described pharmaceutical composition, it is possible to quick to burn and scald in various degree
Alleviating pain and detumescence, anti-infection ability is extremely strong, significantly improves microcirculatory ability, and without using antibiotic, controls
Therapeutic effect is obvious.
The technical solution adopted in the present invention is:
A kind of pharmaceutical composition treating burn and scald, mainly includes that the raw material of following weight portion is made: madder
10-30 part, golden cypress 7-17 part, root of large-flowered skullcap 20-40 part, Radix Angelicae Sinensis 50-80 part, root of Dahurain angelica 20-40 part, giant knotweed 10-30
Part, myrrh 7-17 part, Asian puccoon 30-50 part, Radix Glycyrrhizae 20-40 part, borneol 10-30 part, rheum officinale 35-65
Part, Radix Astragali 10-30 part, safflower 10-30 part, beeswax 30-60 part.
Use the pharmaceutical composition that said ratio is made, it is possible to burn and scald quickly alleviating pain in various degree is subsided a swelling,
Anti-infection ability is extremely strong, significantly improves microcirculatory ability, and without using antibiotic, result for the treatment of is obvious.
For further enhancing the drug effect of described pharmaceutical composition, preferred technical scheme is, drug regimen owner
Raw material including following weight portion is made: 20 parts of madder, golden cypress 12 parts, the root of large-flowered skullcap 30 parts, Radix Angelicae Sinensis 65
Part, the root of Dahurain angelica 30 parts, giant knotweed 20 parts, myrrh 12 parts, Asian puccoon 40 parts, 30 parts of Radix Glycyrrhizae, borneol 20 parts,
Rheum officinale 50 parts, the Radix Astragali 20 parts, 20 parts of safflower, beeswax 45 parts.
Present invention also offers the preparation method of a kind of described pharmaceutical composition, comprise the following steps:
A, remaining the raw material sesame oil except safflower, borneol and beeswax is soaked;
B, by described sesame oil together with raw material therein heat after add safflower, stirring;
C, described sesame oil is filtered while hot after, in filter liquor, add borneol make borneol dissolve;
D, after described borneol all dissolves, add beeswax and after making beeswax all dissolve, cool,
Obtain the described pharmaceutical composition of ointment shape.
Use described preparation method, obtain the pharmaceutical composition of ointment shape, facilitate patient to smear use, directly
Act on burned part, there is onset rapid, advantage easy to use.
Preferably, described preparation method, comprise the following steps:
A, by except safflower, borneol and beeswax remaining raw material with sesame oil soak 4-5 days;The quality of described sesame oil
Part is 800-1000 part;
B, described sesame oil is heated to 140-160 DEG C together with raw material therein, continues 30-60 minute;Rise again
Temperature, to 170-190 DEG C, adds safflower, stirring after continuing 25-45 minute;
C, described sesame oil is filtered while hot, and filter liquor is controlled at 90-110 DEG C, add in filter liquor
Entering borneol makes borneol dissolve;
D, after described borneol all dissolves, add beeswax and after making it all dissolve, cool,
Described pharmaceutical composition to ointment shape.
Part material first use sesame oil soak 4-5 days, it is possible to being fully impregnated with by raw material, follow-up carries
Take work;In heating process, first sesame oil is heated to 140-160 DEG C, continues 30-60 minute, will wherein
The active ingredient preservation as much as possible of raw material extracts, and temperature is less than 140 DEG C or the time was less than 30 minutes
Then extraction efficiency is the lowest, and temperature is too high or overlong time can affect the activity of active ingredient;Again because safflower with
The character of other draft Chinese medicines is different, need to be effective to it under conditions of continuing 25-45 minute at 170-190 DEG C
Composition extracts, temperature less than 170 DEG C or time less than 25 minutes then extraction efficiency the lowest, temperature is too high
Or overlong time can affect the activity of safflower effective ingredients;Again because borneol and beeswax itself can be all to become
It is allocated as using for active ingredient, internal structure can be destroyed when temperature is more than 120 DEG C simultaneously, therefore directly
Add and dissolve use to sesame oil.
For ensureing the quality of final finished, preferred technical scheme is, uses sesame oil to soak raw material in step A
Before, the raw material outside deicing sheet and beeswax dried or shines dry-cure, dry or shine dry-cure successor
In raw material described in, the mass fraction of water is 3-5%.Through drying or shining after dry-cure, the moisture in raw material
Content reduces further, being impregnated with of sesame oil after being conducive to, simultaneously as water content is low, and stablizing of oil phase
Property higher, condition is more preferable, beneficially the finished product of ointment shape preparation, preserve and use.
Further, described drying is carried out in an oven, and described drying and processing is: by described raw material at 60-70 DEG C
Baking oven in dry 8-12h.In the present invention, use no more than the low temperature of 100 DEG C, simultaneously proper extension time
Drying time, dries through row described raw material, the active ingredient being sufficiently reserved in raw material.
For further facilitating the dissolving of described borneol and beeswax, it is maintained at 90-110 DEG C reducing described sesame oil
Time of high temperature, and then reduce the loss of active ingredient, preferred technical scheme is, by described borneol and
Before beeswax adds in described sesame oil, also include pulverization process: described borneol and beeswax are respectively crushed into
The particle of 30-50 mesh.While described particle diameter is prone to processing, drastically reduce the area required dissolution time.
The invention also discloses the application in the medicine of preparation treatment burn and scald of the described pharmaceutical composition.
In order to preferably explain the present invention, below the raw material in the present invention and compatibility relationship are further elaborated.
Madder, formal name used at school: Rubia cordifolia L, for Rubiaceae perennial climbing herb plant.There is cool blood
Invigorate blood circulation, the stasis of blood of dispelling, effect of stimulating the menstrual flow.For spitting blood, bleeding from five sense organs or subcutaneous tissue, metrostaxis, traumatism and bleeding, through close stasis blocking,
Joint pain, tumbling and swelling.
Golden cypress, for the dry bark of rutaceae wampee Phellodendron chinense Schneid., has
Heat-clearing and damp-drying drug, purging intense heat except steaming, effect of detoxification sore treatment, band lower pruritus vulvae red for damp-heat dysentery, jaundice urine,
Heat drenches that puckery pain, tinea pedis impotence be preesed, hectic fever due to yin labor heat, night sweat, seminal emission, sore swollen toxin, the wet sore of eczema.
The root of large-flowered skullcap, for the dry root of the labiate root of large-flowered skullcap.The root of large-flowered skullcap is used as medicine with root, bitter, cold in nature, has heat-clearing
Eliminating dampness, purging intense heat and detonicating, hemostasis, the effect such as antiabortive, cure mainly warm heat disease, the infection of the upper respiratory tract, cough with lung heat,
Damp and hot jaundice, pneumonia, dysentery, hemoptysis, hot eyes, fetal irritability, hypertension, carbuncle swell the diseases such as furuncle sore.
Radix Angelicae Sinensis, for the dry root of umbelliferae angelica Angelica sinensis (Oliv.) Diels, has and enriches blood
Invigorate blood circulation, menstruction regulating and pain relieving, effect of relaxing bowel, be usually used in that the deficiency of blood is sallow, dizziness palpitaition, irregular menstruation,
Through closing dysmenorrhoea, asthenia cold abdominalgia, arthralgia due to wind-dampness, injury from falling down, ulcer sores, the dry constipation of intestines.
The root of Dahurain angelica, for the samphire root of Dahurain angelica or the dry root of Radix angelicae dahuricae.The root of Dahurain angelica is used as medicine with root, the dehumidifying that gets rid of illness,
Apocenosis myogenic, effect of promoting blood circulation and stopping pain, cure mainly anemofrigid cold, headache, rhinitis, toothache, leukorrhea with reddish discharge,
Bitterly furuncle poison etc. disease.
Giant knotweed, for dry rhizome and the root of polygonaceae plant giant knotweed Polygonum cuspidatum Sieb.et Zucc.,
There is dampness removing removing jaundice, clearing heat and detoxicating, blood stasis removing analgesic, relieving cough and reducing sputum effect, for jaundice with damp-heat pathogen, stranguria with turbid discharge,
Under band, arthralgia due to wind-dampness, carbuncle sore tumefacting virus, scald, through closing, abdominal mass, instep beat damage, cough with lung heat.
Myrrh, for olive subject plant Chinese violet tree Commiphora myrrha Engl. or Ha Didingshu
The dry resin of Commiphora molmol Engl., has scattered stasis of blood analgesic therapy, effect of detumescence and promoting granulation, conventional
In chest impediment and cardialgia, gastral cavity pain, dysmenorrhoea through closing, stasis blocking in postpartum, lump in the abdomen stomachache, arthralgia due to wind-dampness, fall beat damage
Wound, carbuncle swell the treatment of the illnesss such as sore.
Asian puccoon, for the dry root of comfrey lithospermum euchromum Royle, Asian puccoon or arnebia guttata Bunge.Asian puccoon nature and flavor are sweet,
Salty, cold, the thoughts of returning home, Liver Channel;Have cool blood, invigorate blood circulation, the effect of promoting eruption of detoxifying, therefore to blood-head poison Sheng, measles,
Macula is thoroughly sent out and is the most freely waited disease, can be with the application of the compatibility such as periostracum cicada, great burdock achene, the capsule of weeping forsythia, schizonepeta.
Radix Glycyrrhizae, for glycyrrhizic legume Glycyrrhiza uralensis Fisch., swollen fruit Radix Glycyrrhizae Glycyrrhiza
InflataBat. or the dry root of glycyrrhiza glabra Glycyrrhiza glabraL. and rhizome, have and invigorate the spleen and benefit qi, clearly
Thermal detoxification, expelling phlegm and arresting coughing, relieving spasm to stop pain, effect of coordinating the drug actions of a prescription, be usually used in weakness of the spleen and the stomach, lassitude hypodynamia,
Palpitation, coughing with a lot of sputum, gastral cavity abdomen, four limbs contraction urgency pain, carbuncle sore tumefacting virus, cushion toxicity, strong.
Borneol, have another name called sheet brain, tangerine sheet, L-Borneol, kapur, MEIHUA BINGPIAN, Dipterocarpus pilosus, plum blossom brain,
Borneol brain, Mei Bing etc., be by composite family Blumea balsamifera cauline leaf or canella borneol camphor tree branches and leaves through steam distillation also
Recrystallizing and obtain, the most useful turpentine oil obtains through a series of chemical method techniques;Borneol can be used for closing card coma,
For red eye, swell pain, larynx numbness aphtha, swell and ache for sore, do not hold back after bursting.
Rheum officinale, for polygonum rheum palmatum Rheum palmatum L., Rheum tanguticum Maxim Rheum
Tanguticum Maxim.ex Balf. or the dry root and rhizome of Rheum officinale Rheum officinale Baill..Greatly
Huang has attacks stagnant, clearing away damp-heat, purging intense heat, cool blood, the stasis of blood of dispelling, effect of removing toxic substances, the logical intestines that are used for purging heat, cool
Blood detoxifies, stimulates the menstrual flow by the stasis of blood.
The Radix Astragali, Classification system Astragalus membranaceus (Fisch.) Bunge, there is enhancing immunity of organism
Function, protect the liver, diuresis, anti-aging, resisting stress, step-down and wide antibacterial action.
Safflower, for the dry flower of feverfew safflower Carthamus tinctorius L., having invigorates blood circulation stimulates the menstrual flow,
Effect of blood stasis removing analgesic.For through closing, dysmenorrhoea, lochia, abdominal mass lump in the abdomen, chest impediment and cardialgia, the stagnant abdomen of the stasis of blood
Bitterly, the shouting pain of the chest side of body, injury from falling down, sore swell and ache.
Beeswax, for the wax of the worker bee such as Apidae insect apis cerana secretion, forms through refined, have removing toxic substances,
Myogenic, effect of analgesic therapy, be used for controlling in anxious the most pained, diarrhea purulence blood, endless diarrhea, vaginal bleeding with fetal movement, sore carbuncle
Attack, for a long time burst do not hold back, scald.
The compatibility relationship of described pharmaceutical composition is: madder, giant knotweed, rheum officinale and myrrh are mainly cool blood, stop
Blood, stagnation resolvation, pain relieving, effect of removing toxicity for detumescence, have collaborative, analgesic activity, it is possible to expansion capilary improves
Microcirculation and anti-inflammatory power, for we's monarch drug in a prescription;Radix Angelicae Sinensis, safflower have promoting blood circulation and removing blood stasis, improve at pathological tissues
Microcirculation ability, assisted the analgesic effect of monarch drug in a prescription, for we ministerial drug;The Radix Astragali, the root of large-flowered skullcap have purging intense heat solution
Poison, hemostatic and antibacterial, effect of myogenic toxin expelling, it is possible to strengthen Effects on local immunological functions and anti-infection ability.Shorten
Treatment cycle, makes medicine for we;Radix Glycyrrhizae, borneol and beeswax have the effect of removing toxic substances pain relieving, to not closing up for a long time
Pain subcutaneous ulcer sore have and well coordinate therapeutic action, diaphragm can be formed at the surface of a wound thus serve stabilizing tissue
The effect of surface of a wound cell membrane, wherein, Radix Glycyrrhizae is first of coordinating the drug actions of a prescription.
The invention have the benefit that
1, the present invention discloses a kind of pharmaceutical composition, coordinated by all medicines, there is cooling blood and hemostasis, detumescence
Pain relieving, purging intense heat and detonicating, effect of removing necrosis and promoting granulation, it is possible to significantly improve the microcirculation ability and more of wound tissue
Conjunction ability, anti-infection ability is superpower, the most odd for light middle severe burn and scald and various trauma surface infestation clinically
Effect.
2, described pharmaceutical composition all has suppression and killing action to the pathogenic bacteria such as Pseudomonas aeruginosa and anaerobic bacteria, its
Anti-infection ability is extremely strong, seldom uses antibiotic in the case of wound drainage is unobstructed, solves abuse at present anti-
While the problem of raw element, also save spending of curing the disease, benefit patient.
3, described pharmaceutical composition can be used not only for Clinical Surgery one to three degree burn and scald and electric injury (skin burning
Burn), moreover it can be used to acid and alkali corrosion wound, bedsore, diabetic's skin of lower extremity itch gangrene always rotten lower limb and
Other surgical infection surface of a wound.
4, present invention also offers the preparation method of a kind of described pharmaceutical composition, use described preparation method,
Easily operated, at utmost remain the active ingredient in described raw material;Obtain the pharmaceutical composition of ointment shape,
Facilitate patient to smear use, directly act on burned part, there is onset rapid, advantage easy to use.
Detailed description of the invention
Below in conjunction with embodiment, further illustrate present disclosure.Should be appreciated that the enforcement of the present invention
Being not limited to the following examples, any pro forma accommodation and/or the change of being made the present invention all will fall
Enter scope.
In the present invention, if not refering in particular to, all of part, percentage are unit of weight, all of equipment and
Raw materials etc. are all commercially available or the industry is conventional.Method in following embodiment, as without saying especially
Bright, it is the conventional method of this area.
Embodiment 1
The invention provides a kind of pharmaceutical composition treating burn and scald, mainly include the raw material of following weight portion
Make: madder 1kg, golden cypress 1.7kg, root of large-flowered skullcap 2kg, Radix Angelicae Sinensis 8kg, root of Dahurain angelica 2kg, giant knotweed 3kg, myrrh
0.7kg, Asian puccoon 5kg, Radix Glycyrrhizae 2kg, borneol 3kg, rheum officinale 3.5kg, Radix Astragali 3kg, safflower 1kg, beeswax
6kg。
The preparation method of a kind of described pharmaceutical composition, comprises the following steps:
A, by except safflower, borneol and beeswax remaining raw material with 80kg sesame oil soak 5 days;
B, described sesame oil is heated to 160 DEG C together with raw material therein, continues 30 minutes;It is warming up to 190 DEG C again,
Safflower, stirring is added after continuing 25 minutes;
C, described sesame oil is filtered while hot, discard filter residue, and filter liquor is controlled at 110 DEG C, to filtration
Adding borneol in filtrate makes borneol dissolve;
D, after described borneol all dissolves, add beeswax and after making beeswax all dissolve, cool,
Obtain the described pharmaceutical composition of ointment shape.
Embodiment 2
The invention provides a kind of pharmaceutical composition treating burn and scald, mainly include the raw material of following weight portion
Make: madder 3kg, golden cypress 0.7kg, root of large-flowered skullcap 4kg, Radix Angelicae Sinensis 5kg, root of Dahurain angelica 4kg, giant knotweed 1kg, myrrh
1.7kg, Asian puccoon 3kg, Radix Glycyrrhizae 4kg, borneol 1kg, rheum officinale 6.5kg, Radix Astragali 1kg, safflower 3kg, beeswax
3kg。
The preparation method of a kind of described pharmaceutical composition, comprises the following steps:
A, carry out the raw material outside deicing sheet and beeswax shining dry-cure, shine raw material described in dry-cure successor one
The mass fraction of middle water is 3-5%;
B, by except safflower, borneol and beeswax remaining raw material with 100kg sesame oil soak 4 days;
C, described sesame oil is heated to 140 DEG C together with raw material therein, continues 60 minutes;It is warming up to 170 DEG C again,
Safflower, stirring is added after continuing 45 minutes;
D, described sesame oil is filtered while hot, discard filter residue, and filter liquor is controlled at 90 DEG C, to filtration
Adding borneol in filtrate makes borneol dissolve;Before described borneol is added in described sesame oil, by described borneol
It is ground into the particle of 30 mesh;
E, after described borneol all dissolves, add beeswax and after making beeswax all dissolve, cool,
Described pharmaceutical composition to ointment shape.Before described beeswax is added in described sesame oil, by described beeswax
It is ground into the particle of 30 mesh.
Embodiment 3
The invention provides a kind of pharmaceutical composition treating burn and scald, mainly include the raw material of following weight portion
Make: madder 1kg, golden cypress 1.7kg, root of large-flowered skullcap 2kg, Radix Angelicae Sinensis 8kg, root of Dahurain angelica 2kg, giant knotweed 3kg, myrrh
0.7kg, Asian puccoon 5kg, Radix Glycyrrhizae 2kg, borneol 3kg, rheum officinale 3.5kg, Radix Astragali 3kg, safflower 1kg, beeswax
6kg。
The preparation method of a kind of described pharmaceutical composition, comprises the following steps:
A, the raw material outside deicing sheet and beeswax is dried 12h, drying and processing successor in the baking oven of 60 DEG C
In raw material described in, the mass fraction of water is 3-5%;
B, by except safflower, borneol and beeswax remaining raw material with 80kg sesame oil soak 5 days;
B, described sesame oil is heated to 160 DEG C together with raw material therein, continues 30 minutes;It is warming up to 190 DEG C again,
Safflower, stirring is added after continuing 25 minutes;
C, described sesame oil is filtered while hot, discard filter residue, and filter liquor is controlled at 110 DEG C, to filtration
Adding borneol in filtrate makes borneol dissolve;Before described borneol is added in described sesame oil, by described borneol
It is ground into the particle of 50 mesh;
D, after described borneol all dissolves, add beeswax and after making beeswax all dissolve, cool,
Obtain the described pharmaceutical composition of ointment shape.Before described beeswax is added in described sesame oil, by described honey
Wax is ground into the particle of 50 mesh.
Embodiment 4
The invention provides a kind of pharmaceutical composition treating burn and scald, mainly include the raw material of following weight portion
Make: madder 3kg, golden cypress 0.7kg, root of large-flowered skullcap 4kg, Radix Angelicae Sinensis 5kg, root of Dahurain angelica 4kg, giant knotweed 1kg, myrrh
1.7kg, Asian puccoon 3kg, Radix Glycyrrhizae 4kg, borneol 1kg, rheum officinale 6.5kg, Radix Astragali 1kg, safflower 3kg, beeswax
3kg。
The preparation method of a kind of described pharmaceutical composition, comprises the following steps:
A, the raw material outside deicing sheet and beeswax is dried in the baking oven of 70 DEG C 8h, arbitrary after drying and processing
In described raw material, the mass fraction of water is 3-5%;
B, by except safflower, borneol and beeswax remaining raw material with 100kg sesame oil soak 4 days;
C, described sesame oil is heated to 140 DEG C together with raw material therein, continues 60 minutes;It is warming up to 170 DEG C again,
Safflower, stirring is added after continuing 45 minutes;
D, described sesame oil is filtered while hot, discard filter residue, and filter liquor is controlled at 90 DEG C, to filtration
Adding borneol in filtrate makes borneol dissolve;Before described borneol is added in described sesame oil, by described borneol
It is ground into the particle of 30 mesh;
E, after described borneol all dissolves, add beeswax and after making beeswax all dissolve, cool,
Described pharmaceutical composition to ointment shape.Before described beeswax is added in described sesame oil, by described beeswax
It is ground into the particle of 30 mesh.
Embodiment 5
The invention provides a kind of pharmaceutical composition treating burn and scald, mainly include the raw material of following weight portion
Make: madder 2kg, golden cypress 1.2kg, root of large-flowered skullcap 3kg, Radix Angelicae Sinensis 6.5kg, root of Dahurain angelica 3kg, giant knotweed 2kg, do not have
Medicine 1.2kg, Asian puccoon 4kg, Radix Glycyrrhizae 3kg, borneol 2kg, rheum officinale 5kg, Radix Astragali 2kg, safflower 2kg, honey
Wax 4.5kg.
The preparation method of a kind of described pharmaceutical composition, comprises the following steps:
A, the raw material outside deicing sheet and beeswax is dried 10h, drying and processing successor in the baking oven of 65 DEG C
In raw material described in, the mass fraction of water is 3-5%;
B, by except safflower, borneol and beeswax remaining raw material with 90kg sesame oil soak 4 days;
C, described sesame oil is heated to 150 DEG C together with raw material therein, continues 45 minutes;It is warming up to 180 DEG C again,
Safflower, stirring is added after continuing 35 minutes;
D, described sesame oil is filtered while hot, discard filter residue, and filter liquor is controlled at 100 DEG C, to filtration
Adding borneol in filtrate makes borneol dissolve;Before described borneol is added in described sesame oil, by described borneol
It is ground into the particle of 40 mesh;
E, after described borneol all dissolves, add beeswax and after making beeswax all dissolve, cool,
Described pharmaceutical composition to ointment shape.Before described beeswax is added in described sesame oil, by described beeswax
It is ground into the particle of 40 mesh.
The invention also discloses the application in the medicine of preparation treatment burn and scald of the described pharmaceutical composition.
As a example by embodiment 5, during use by scraper needed amount by the described pharmaceutical composition of ointment shape gently
Scraping is to affected part.
The therapeutic test below done for the described pharmaceutical composition in the present invention:
(1), testing crew physical data
Selecting various burned patient 200 example, in 200 example burned patients, M-F is 1:1, the age
16~57 years old and in normal distribution, 36 years old mean age.
(2), testing crew diagnosis basis
With whole nation higher medical institute teaching material " clinical practice " and " surgery " as standard, with clinical manifestation, doctor
It is foundation that institute's diagnosis, report and burn surface area percentage calculate method, carries out reference, gets rid of Other diseases.
(3), test method
According to above-mentioned using method, by scraper needed amount, the described pharmaceutical composition of ointment shape is swiped gently
To affected part, depending on coincident with severity degree of condition, smearing continuously 60 days, if curing, discontinuing medication.
(4), curative effect determinate standard and result
Cure: clinical symptoms are wholly absent, recover normal life 145 example, cure rate 72.5%
Taking a turn for the better: clinical symptoms partial disappearance, every sign progressively takes a turn for the better 51 examples, improvement rate 25.5%
Cure and take a turn for the better and all count effectively statistics: have 196 examples, total effective rate 98%
Invalid: symptom and sign is not improved 4 examples, inefficiency 2%.
(5), conclusion
From result it can be seen that described pharmaceutical composition has the advantage that cure rate is high.
(6), the concrete case of part:
1, Wang, man, 29 years old, Taiyuan, Shanxi people, the most scalding, arm, shirtfront occurred
A large amount of bubbles, area reaches 10%, is diagnosed as two degree of shallow scalds, after the pharmaceutical composition in the use present invention about
Pain relief in 10 minutes, patient is epidermis incrustation after 7 days, the recovery from illness of two weeks, does not has scar.
2, Lee, man, 38 years old, people from Pingxiang, Jiangxi Province, high-voltage electrical burns Head And Face and double upper limbs, table
Skin has burnt crackle sample, and its burn surface area reaches 18%, is diagnosed as two degree and is deep to third-degree burn.Use in the present invention
Pharmaceutical composition, after one day, illing skin has moist feeling.After 8 days, surface of a wound skin portion comes off, after 20 days
Surface of a wound incrustation produces, and the major part that forms a scab after about 30 comes off.There is no scar, after half a year, recover original skin condition.
3, the summer, female, 44 years old, people from Yichuan, Jiangxi Province, scalded double lower limb by water vapour, color is that purple is dark
Look, area reaches 13%, is diagnosed as third-degree burn.Use the pharmaceutical composition in the present invention, after about 20 minutes
Pain relief.Surface of a wound in-situ regeneration incrustation after 10 days, the excoriation after the surface of a wound is formed a scab after 30 days, three months
The original skin condition of rear recovery.
4, Jiao, female, 30 years old, starfish people from county of Hebei province, because thermos flask blast is burned facial area, examines
Breaking is two degree of shallow scalds, and area is 3%, uses the pharmaceutical composition in the present invention, fully recovers after 15 days.
5, Zhang, man, 45 years old, people from Wudi County, Shandong Province, it is not cautious use of caustic soda and burns right lower extremity, area reaches
13%, it is diagnosed as caustic soda high corrosion wound.Epidermis is pale, and around redness has heat pain, uses in the present invention
Pharmaceutical composition, after about 15 minutes, pain substantially alleviates.Through changing dressings two days, caustic soda has not continued to corrosion,
After medication 5 days, there are mild pain sense, red and swollen disappearance.15 days surface of a wound of medication have healed 60%, under naked eyes
Surface of a wound substrate pinkiness, one month surface of a wound all healed of medication, formed without scar.
It should be noted last that, above example only in order to technical scheme to be described and unrestricted,
Although the present invention being described in detail with reference to preferred embodiment, be it should be understood that and be the foregoing is only
The detailed description of the invention of the present invention, the protection domain being not intended to limit the present invention, all the present invention's
Within spirit and principle, any modification, equivalent substitution and improvement etc. done, should be included in the present invention's
Within protection domain.
Claims (8)
1. the pharmaceutical composition treating burn and scald, it is characterised in that mainly include following weight portion
Raw material is made: madder 10-30 part, golden cypress 7-17 part, root of large-flowered skullcap 20-40 part, Radix Angelicae Sinensis 50-80 part, the root of Dahurain angelica
20-40 part, giant knotweed 10-30 part, myrrh 7-17 part, Asian puccoon 30-50 part, Radix Glycyrrhizae 20-40 part, borneol 10-30
Part, rheum officinale 35-65 part, Radix Astragali 10-30 part, safflower 10-30 part, beeswax 30-60 part.
Pharmaceutical composition the most according to claim 1, it is characterised in that mainly include following weight
Part raw material make: 20 parts of madder, golden cypress 12 parts, the root of large-flowered skullcap 30 parts, Radix Angelicae Sinensis 65 parts, the root of Dahurain angelica 30 parts,
Giant knotweed 20 parts, myrrh 12 parts, Asian puccoon 40 parts, 30 parts of Radix Glycyrrhizae, borneol 20 parts, rheum officinale 50 parts, Huang
Stilbene 20 parts, 20 parts of safflower, beeswax 45 parts.
3. the preparation method of pharmaceutical composition described in a claim 1 or 2, it is characterised in that include
Following steps:
A, remaining the raw material sesame oil except safflower, borneol and beeswax is soaked;
B, by described sesame oil together with raw material therein heat after add safflower, stirring;
After C, while hot filtration, in filter liquor, add borneol and make borneol dissolve;
D, after described borneol all dissolves, add beeswax and after making beeswax all dissolve, cool,
Obtain the described pharmaceutical composition of ointment shape.
Preparation method the most according to claim 3, it is characterised in that comprise the following steps:
A, by except safflower, borneol and beeswax remaining raw material with sesame oil soak 4-5 days;The quality of described sesame oil
Part is 800-1000 part;
B, described sesame oil is heated to 140-160 DEG C together with raw material therein, continues 30-60 minute;Rise again
Temperature, to 170-190 DEG C, adds safflower, stirring after continuing 25-45 minute;
C, described sesame oil is filtered while hot, and filter liquor is controlled at 90-110 DEG C, add in filter liquor
Enter borneol and make borneol dissolve;
D, after described borneol all dissolves, add beeswax and after making it all dissolve, cool,
Described pharmaceutical composition to ointment shape.
Preparation method the most according to claim 4, it is characterised in that use sesame oil leaching in step A
Before bubble raw material, the raw material outside deicing sheet and beeswax dried or shines dry-cure, dry or dry place
After reason, in arbitrary described raw material, the mass fraction of water is 3-5%.
Preparation method the most according to claim 5, it is characterised in that described drying and processing is: will
Described raw material dries 8-12h in the baking oven of 60-70 DEG C.
Preparation method the most according to claim 4, it is characterised in that described borneol and beeswax add
Before, pulverization process is also included: described borneol and beeswax are respectively crushed into the particle of 30-50 mesh.
8. the arbitrary described pharmaceutical composition of claim 1 or 2 answering in the medicine of preparation treatment burn and scald
With.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610160769.9A CN105770116A (en) | 2016-03-21 | 2016-03-21 | Medicine composition for treating burn and scald, method for preparing medicine composition and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610160769.9A CN105770116A (en) | 2016-03-21 | 2016-03-21 | Medicine composition for treating burn and scald, method for preparing medicine composition and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105770116A true CN105770116A (en) | 2016-07-20 |
Family
ID=56393070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610160769.9A Pending CN105770116A (en) | 2016-03-21 | 2016-03-21 | Medicine composition for treating burn and scald, method for preparing medicine composition and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105770116A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106214824A (en) * | 2016-08-15 | 2016-12-14 | 韦丽丽 | A kind of medicine treating dermatosis and scald and preparation method thereof |
CN107519335A (en) * | 2017-10-10 | 2017-12-29 | 金得成 | A kind of liquid medicine for treating empyrosis |
CN110559361A (en) * | 2019-08-23 | 2019-12-13 | 王托资 | Erhuang scorpion gallbladder ointment and its preparation method |
CN114344379A (en) * | 2022-01-19 | 2022-04-15 | 陈林 | Herbal medicine formula for treating general ulceration and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579820A (en) * | 2011-01-07 | 2012-07-18 | 韦军来 | Ointment for treating burns and scalds and preparation method of ointment |
-
2016
- 2016-03-21 CN CN201610160769.9A patent/CN105770116A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579820A (en) * | 2011-01-07 | 2012-07-18 | 韦军来 | Ointment for treating burns and scalds and preparation method of ointment |
Non-Patent Citations (2)
Title |
---|
朱勤等: ""复方虎杖烧伤油膏的研制与临床应用"", 《福建药学杂志》 * |
王珠劳等: ""复方紫草油治疗烧烫伤305例"", 《新中医》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106214824A (en) * | 2016-08-15 | 2016-12-14 | 韦丽丽 | A kind of medicine treating dermatosis and scald and preparation method thereof |
CN107519335A (en) * | 2017-10-10 | 2017-12-29 | 金得成 | A kind of liquid medicine for treating empyrosis |
CN110559361A (en) * | 2019-08-23 | 2019-12-13 | 王托资 | Erhuang scorpion gallbladder ointment and its preparation method |
CN114344379A (en) * | 2022-01-19 | 2022-04-15 | 陈林 | Herbal medicine formula for treating general ulceration and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105770116A (en) | Medicine composition for treating burn and scald, method for preparing medicine composition and application thereof | |
WO2012100754A1 (en) | Chinese medicine composition for treating stab wounds, burns, and various traumas | |
CN102716334B (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
CN103845578A (en) | External tincture for treating burns, bedsore and herpes zoster and preparation method thereof | |
CN101647973B (en) | Externally applied liquid medicine for treating dermatoneuritis and preparation method thereof | |
CN102846739B (en) | Navel-applied plaster for treating hepatitis and preparation method thereof | |
CN103908600A (en) | Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof | |
CN101347549B (en) | Medicament composition for treating intumescence and infection contamination of navel section of newborn infant as well as preparation method thereof | |
CN103977367A (en) | Traditional Chinese medicament for treating qi-stagnation blood-aggregation type bedsore and preparation method thereof | |
CN103142727B (en) | Chinese herbal medicine composition for treating burning and scalding of human body | |
CN104997918A (en) | Foot tinea treating traditional Chinese medicine composition | |
CN104398741A (en) | Traditional Chinese medicinal preparation for treating osteomyelitis | |
CN103520594B (en) | Traditional Chinese medicine for treating interior dampness-heat syndrome type acne disease | |
CN102631660A (en) | Chinese medicament for treating intestinal obstruction | |
CN104644870A (en) | Traditional Chinese medicine for treating dry eye syndrome | |
CN104815246A (en) | Medicine used for nursing and treating burn due to invasion of interior by toxic fire and preparation method of medicine | |
CN103479917B (en) | Traditional Chinese medicine composition for treating burns and scalds | |
CN103638174B (en) | Traditional Chinese medicine for treating haemorrhoids | |
CN104474452A (en) | Medicine for treating blood coagulation and toxin accumulating bedsore and preparation method of medicine | |
CN104083649A (en) | Traditional Chinese medicine preparation for treating shoulder periarthritis | |
CN105267318A (en) | Chinese patent medicine for eliminating ostealgia | |
CN103735699A (en) | Traditional Chinese medicinal composition for treating scald and preparation method thereof | |
CN103536892A (en) | Traditional Chinese medicine for treating infertility of syndrome of yang deficiency and coagulated cold | |
CN113304239A (en) | Preparation method of traditional Chinese medicine patch for arthralgia | |
CN103007238A (en) | Traditional Chinese medicine composition for treating decubitus ulcers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160720 |
|
RJ01 | Rejection of invention patent application after publication |